EVOL SCIENCE

Evol Science is a startup biotechnology company focused on identifying and therapeutically exploiting mechanisms of cancer cell resistance, which they discover using their proteo-genomic system and proprietary AI-driven data analytic platform. Evol's platform identifies and targets cancer cell drug resistance, acquired and intrinsic, accelerating and de-risking drug development and clinical translation. They generate a novel pipeline for our BioPharma partners and license out our IP, expanding... their patient reach. Evol’s first biological discovery has generated multiple novel drug combinations to treat late-stage, RAS-driven cancers including metastatic melanoma, pancreatic, colorectal, breast, and lung. They expect to have their first combination in proof-of-principle clinical trials in the first half of 2019. Their goal is to make the deadliest cancers survivable.More